Severe thrombocytopenia in myelofibrosis is more prevalent than previously reported

Lucia Masarova; Ruben Anthony Mesa; Juan C. Hernández-Boluda; Jason A. Taylor

doi:10.1016/j.leukres.2020.106338

Severe thrombocytopenia in myelofibrosis is more prevalent than previously reported

Lucia Masarova, Ruben Anthony Mesa, Juan C. Hernández-Boluda, Jason A. Taylor

Leukemia

Research output: Contribution to journal › Letter › peer-review

11 Scopus citations

Original language	English (US)
Article number	106338
Journal	Leukemia Research
Volume	91
DOIs	https://doi.org/10.1016/j.leukres.2020.106338
State	Published - Apr 2020

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1016/j.leukres.2020.106338

Cite this

@article{347f8321afc9428486debf25952a7d92,

title = "Severe thrombocytopenia in myelofibrosis is more prevalent than previously reported",

author = "Lucia Masarova and Mesa, {Ruben Anthony} and Hern{\'a}ndez-Boluda, {Juan C.} and Taylor, {Jason A.}",

note = "Funding Information: JAT is an employee of CTI Biopharma, Seattle WA, United States, who funded the research in this letter. RAM is a consultant for Novartis, La Jolla, and Sierra Oncology and he receives research support from CTI, Incyte, Celgene, Abbvie. LM and JCHB have no COI.",

year = "2020",

month = apr,

doi = "10.1016/j.leukres.2020.106338",

language = "English (US)",

volume = "91",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Severe thrombocytopenia in myelofibrosis is more prevalent than previously reported

AU - Masarova, Lucia

AU - Mesa, Ruben Anthony

AU - Hernández-Boluda, Juan C.

AU - Taylor, Jason A.

N1 - Funding Information: JAT is an employee of CTI Biopharma, Seattle WA, United States, who funded the research in this letter. RAM is a consultant for Novartis, La Jolla, and Sierra Oncology and he receives research support from CTI, Incyte, Celgene, Abbvie. LM and JCHB have no COI.

PY - 2020/4

Y1 - 2020/4

UR - http://www.scopus.com/inward/record.url?scp=85081258856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081258856&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2020.106338

DO - 10.1016/j.leukres.2020.106338

M3 - Letter

C2 - 32200188

AN - SCOPUS:85081258856

SN - 0145-2126

VL - 91

JO - Leukemia Research

JF - Leukemia Research

M1 - 106338

ER -

Severe thrombocytopenia in myelofibrosis is more prevalent than previously reported

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this